Shelves: world-war-i , maritime-history Dreadnought is the story of the naval arms race between England and Germany leading up to World War I. Now, anyone who has taken the time to think about World War I knows that it is a nearly-intractable subject when it comes its genesis. We all learn in school about the myriad entangling alliances, in which a number of triggers built into a series of treaties flipped one by one, like a perverse game of dominoes. Or something like that. We know the mechanics.
|Published (Last):||27 August 2018|
|PDF File Size:||15.4 Mb|
|ePub File Size:||6.40 Mb|
|Price:||Free* [*Free Regsitration Required]|
Email: obentur rockefeller. Current Research Protocol Title: Identification of genetic modifiers that ameliorate the clinical severity of patients with hemophilia Bio: Dr. He completed his internal medicine residency and hematology fellowship at the Tel Aviv Medical Center, Israel.
As a Clinical Scholar, Dr. Bentur will focus on molecular analysis of patients with bleeding disorders and genotype-phenotype correlation analysis in these patients. He will try to identify genetic modifiers in patients with less severe bleeding symptoms than expected based on the severity of their coagulation abnormality. He completed his dermatology residency with the Australasian College of Dermatologists, Australia. Frew will study Hidradenitis Suppurativa, a debilitating and largely neglected inflammatory skin disease.
He will focus on the mechanisms of innate immune dysregulation with the goal of unravelling the complex contributions of genetic factors and environmental triggers such as smoking, obesity and metabolic syndrome.
He will also examine the role of alterations to the microbiome in perpetuating the ongoing inflammatory cascade in this disorder with the aim of identifying and developing new treatments for this disease. Gaebler is studying broadly neutralizing antibodies to HIV Such anti-HIV-1 antibodies have been shown to effectively control virus replication in animal model systems and in human antibody treatment studies.
His current research focuses on the characterization of the HIV-1 latent reservoir. Irmady is a graduate of Mysore Medical College, India following which she received her doctoral degree from the University of Heidelberg, Germany. She completed her residency training in neurology at Yale New Haven Hospital and is currently pursuing a fellowship in movement disorders at Columbia University.
Current Research Protocol Title: A phase 1, open-label study to assess the safety and tolerability of the Fc-engineered variant V11 in patients with tumors of the skin amenable to intratumoral injection Bio: Dr. Knorr will focus on improving immune therapy of cancer by activating CD40 on immune cells with specifically-engineered antibodies. This has the potential to provide another class of drugs that can help the immune system attack and kill cancer cells.
Maxwell will study genetic factors that increase susceptibility to both oncogenesis and cancer treatment-related toxicities. Her specific research interest is identifying the functional mechanism by which alternations in genes causing Fanconi anemia increase the risk of developing malignancies.
Current Clinical Scholars
Impact of hemophilia home therapy program on a regional blood center.
Maujin A multicenter randomized controlled trial. TRALI not a two hit, but a multi-causal model. Camila Caram-Deelder, MSc, from the Center for Clinical Transfusion Research in Leiden, the Netherlands, and colleagues conducted a retrospective cohort study of first-ever transfusion recipients from May 30,to September 1,in 6 major Dutch hospitals. Alloexposed blood donors and transfusion-related acute lung injury: Transfusion-related acute lung injury not a two-hit, but a multicausal model.